Literature DB >> 31501732

A Case Report of IgA Nephropathy Coexisting with Focal Segmental Glomerulosclerosis.

Hassaan Iftikhar1, Maryam Saleem2, Anand Kaji1.   

Abstract

IgA nephropathy is a condition characterized by deposition of IgA immunoglobulin in the glomerulus. This condition is fairly common in Western countries. The disease spectrum is broad and it varies case to case. The cases of IgA nephropathy associated with focal segmental glomerulosclerosis are rare. Our case report is about a young male who developed rapid onset IgA nephropathy leading to end stage renal disease (ESRD).

Entities:  

Keywords:  fsgs; glomerulonephritis; iga; nephropathy

Year:  2019        PMID： 31501732      PMCID： PMC6721872          DOI： 10.7759/cureus.5040

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  17 in total

Review 1.  IgA nephropathy.

Authors:  James V Donadio; Joseph P Grande
Journal:  N Engl J Med       Date:  2002-09-05       Impact factor: 91.245

2.  Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

Authors:  Hitoshi Suzuki; Run Fan; Zhixin Zhang; Rhubell Brown; Stacy Hall; Bruce A Julian; W Winn Chatham; Yusuke Suzuki; Robert J Wyatt; Zina Moldoveanu; Jeannette Y Lee; James Robinson; Milan Tomana; Yasuhiko Tomino; Jiri Mestecky; Jan Novak
Journal:  J Clin Invest       Date:  2009-05-26       Impact factor: 14.808

3.  A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy.

Authors:  A Chang; J Kowalewska; K D Smith; R F Nicosia; C E Alpers
Journal:  Clin Nephrol       Date:  2006-12       Impact factor: 0.975

4.  A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.

Authors:  Kenji Wakai; Takashi Kawamura; Masayuki Endoh; Masayo Kojima; Yasuhiko Tomino; Akiko Tamakoshi; Yoshiyuki Ohno; Yutaka Inaba; Hideto Sakai
Journal:  Nephrol Dial Transplant       Date:  2006-07-05       Impact factor: 5.992

5.  Epidemiologic data of primary glomerular diseases in western France.

Authors:  Pierre Simon; Marie-Paule Ramee; Rehouni Boulahrouz; Corina Stanescu; Christophe Charasse; Kim Seng Ang; Françoise Leonetti; Gérard Cam; Eric Laruelle; Valérie Autuly; Nathalie Rioux
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

6.  Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.

Authors:  Catherine L Weber; Caren L Rose; Alex B Magil
Journal:  Nephrol Dial Transplant       Date:  2008-09-11       Impact factor: 5.992

7.  The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

Authors:  Daniel C Cattran; Rosanna Coppo; H Terence Cook; John Feehally; Ian S D Roberts; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Chi Bon Leung; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

8.  Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial.

Authors:  Manuel Praga; Eduardo Gutiérrez; Ester González; Enrique Morales; Eduardo Hernández
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

Review 9.  Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Authors:  J Mestecky; M Tomana; Z Moldoveanu; B A Julian; H Suzuki; K Matousovic; M B Renfrow; L Novak; R J Wyatt; J Novak
Journal:  Kidney Blood Press Res       Date:  2008-01-08       Impact factor: 2.687

10.  Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.

Authors:  James A Tumlin; Verachai Lohavichan; Randy Hennigar
Journal:  Nephrol Dial Transplant       Date:  2003-07       Impact factor: 5.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.